(Nasdaq: CODX) ("Co-Dx" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today highlighted capabilities of its ...
The question quickly arose whether existing rapid antigen tests could detect newly emerging variants. Using clinical samples obtained from diagnostic labs throughout the U.S. from 2020 to 2023, the ...
The US Food and Drug Administration has cleared a new multiplex gastrointestinal PCR assay designed to streamline the detection of common diarrhea-causing pathogens from a single patient sample. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results